W. Va. Code R. § 14-2-7 - Drug Formulary

Current through Register Vol. XXXIX, No. 11, March 18, 2022

7.1. Licensees certified under the provisions of this rule may prescribe the drugs set forth in W. Va. Code §§ 30-8-9, 30-8-14 and this section.
7.2. W. Va. Code § 30-8-6 authorizes the Board to develop a formulary of categories of oral drugs to be considered rational to the diagnosis and treatment of visual defects or abnormal conditions of the human eye and its appendages from Schedules III, IV and V, excluding Schedule I and Schedule II of the Uniform Controlled Substances Act. The categories include:
7.2.a. Oral Antibiotics;
7.2.b. Oral Nonsteroidal Anti-inflamatory Drugs;
7.2.c. Oral Carbonic Anhydrase Inhibitors;
7.2.d. Antihistamines;
7.2.e. Oral Corticosteroids, may be prescribed for a duration of no more than six days;
7.2.f. Analgesics, provided that no oral narcotic analgesic may be prescribed for a duration of more than three days; and
7.2.g. Nutritional Supplements.
7.2.h. New drugs or new drug indications from Schedules III, IV and V, excluding Schedule I and Schedule II of the Uniform Controlled Substances Act which, regardless of their listed classification, have been shown to be effective in the examination, diagnosis or treatment of diseases and conditions of the human eye and its appendages may be approved by the Board according to the provisions of W. Va. Code §§ 30-8-9 and 30-8-14.
7.2.i. A list of approved new drugs and new drug indications proven to be effective in the examination, diagnosis or treatment of diseases and conditions of the human eye and its appendages will be maintained by the Board for public inspection.
7.2.j. The approval of Schedule I and Schedule II drugs is prohibited.

Notes

W. Va. Code R. § 14-2-7

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.